Long-term clozapine use associated with increased odds of haematological malignancies: Lancet Dr. Shravani Dali27 March 2022 11:45 PM GMTLong-term clozapine use is associated with increased odds of haematological malignancies, according to a recent study published in The Lancet...
Study defines new therapeutic window for Amisulpride in Asian Schizophrenic patients. Dr. Shivi Kataria7 Sep 2021 3:30 AM GMTIn the treatment of schizophrenia, atypical antipsychotics are replacing typical antipsychotics. As an atypical antipsychotic for D2, D3 and 5-HT7...
Yoga therapy could improve social cognition in schizophrenia, NIMHANS study Dr. Shivi Kataria23 Aug 2021 3:30 AM GMTAn experimental medicine-based randomized controlled trial conducted by NIMHANS, Bengaluru has shown that 6 weeks of add-on yoga therapy could improve...
Lurasidone- Antipsychotic with minimal impact on metabolic profile in young patients Dr. Shivi Kataria26 May 2021 3:30 AM GMTSchizophrenia (SCZ) commonly manifests in adolescent age group and atypical antipsychotics are recommended as its first-line treatment. However, these...
Digital therapy SlowMo may benefit paranoia, JAMA study. Dr. Shivi Kataria11 April 2021 4:30 PM GMTParanoia is among the most common symptoms of schizophrenia spectrum disorders and is associated with substantial distress and disruption and thus...
New analysis method of functional MRI may improve schizophrenia treatment MD Bureau30 Jun 2020 5:15 AM GMTNew York- Researchers have developed tools to improve the analysis of functional magnetic resonance imaging (fMRI) data which may pave the way for...
